(Q73274858)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Thomas Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Thomas Büttner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ali Farshad Gholipour

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Wilfried Kuhn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

8 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12697283

full work available at URL

24 December 2023

https://api.elsevier.com/content/article/PII:S030439400300185X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0304-3940(03)00185-X

https://api.elsevier.com/content/article/PII:S030439400300185X?httpAccept=text/plain

24 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0304-3940(03)00185-X

24 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

201-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

Distorted color discrimination in 'de novo' parkinsonian patients

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Assessment of coenzyme Q10 tolerability in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Lovastatin decreases coenzyme Q levels in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Dopamine release in human ventral striatum and expectation of reward

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

The biochemical bases for reward. Implications for the placebo effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Proposals for scoring and assessing the 100-Hue test.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Distorted colour discrimination in Parkinson's disease is related to severity of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Progress of visual dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Coenzyme Q10 in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Effects of age and dietary antioxidants on cerebral electron transport chain activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Q10 therapy in patients with idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900185-X

7 January 2021

Decreased dopamine in the retinas of patients with Parkinson's disease

8

1 reference

https://api.crossref.org/works/10.1016/S0304-3940(03)00185-X

24 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12697283%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference